2-[1-[3-(dimethylamino)phenyl]-4-methylimidazol-2-yl]sulfanylacetic acid

C14H17N3O2S — CID 115378964

IUPAC2-[1-[3-(dimethylamino)phenyl]-4-methylimidazol-2-yl]sulfanylacetic acid
SMILESCc1cn(-c2cccc(N(C)C)c2)c(SCC(=O)O)n1
InChIInChI=1S/C14H17N3O2S/c1-10-8-17(14(15-10)20-9-13(18)19)12-6-4-5-11(7-12)16(2)3/h4-8H,9H2,1-3H3,(H,18,19)
InChIKeySWIRMTQXXBZEJC-UHFFFAOYSA-N
MW291.38 g/mol
LogP2.42
Rot. Bonds5

About 2-[1-[3-(dimethylamino)phenyl]-4-methylimidazol-2-yl]sulfanylacetic acid

2-[1-[3-(dimethylamino)phenyl]-4-methylimidazol-2-yl]sulfanylacetic acid (PubChem CID 115378964) has the molecular formula C14H17N3O2S and a molecular weight of 291.38 g/mol. Its IUPAC name is 2-[1-[3-(dimethylamino)phenyl]-4-methylimidazol-2-yl]sulfanylacetic acid.

Molecular Properties

Compound Name2-[1-[3-(dimethylamino)phenyl]-4-methylimidazol-2-yl]sulfanylacetic acid
PubChem CID115378964
Molecular FormulaC14H17N3O2S
Molecular Weight291.38 g/mol
Exact Mass291.10
IUPAC Name2-[1-[3-(dimethylamino)phenyl]-4-methylimidazol-2-yl]sulfanylacetic acid
SMILESCc1cn(-c2cccc(N(C)C)c2)c(SCC(=O)O)n1
InChIInChI=1S/C14H17N3O2S/c1-10-8-17(14(15-10)20-9-13(18)19)12-6-4-5-11(7-12)16(2)3/h4-8H,9H2,1-3H3,(H,18,19)
InChIKeySWIRMTQXXBZEJC-UHFFFAOYSA-N
XLogP2.42
TPSA58.36 Ų
H-Bond Donors1
H-Bond Acceptors5
Rotatable Bonds5
Heavy Atoms20
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500291.38
LogP ≤ 52.42
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 105

Analyze 2-[1-[3-(dimethylamino)phenyl]-4-methylimidazol-2-yl]sulfanylacetic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

2-[1-[4-(dimethylamino)phenyl]-4-methylimidazol-2-yl]sulfanylacetic acid
CID 81337221
2-[1-(3-chlorophenyl)-4-methylimidazol-2-yl]sulfanylacetic acid
CID 81335869
2-[1-(3-iodophenyl)-4-methylimidazol-2-yl]sulfanylacetic acid
CID 81336856
2-[1-[3-(dimethylamino)-4-methylphenyl]-4-methylimidazol-2-yl]sulfanylacetic acid
CID 115378966
2-(4-methyl-1-quinolin-6-ylimidazol-2-yl)sulfanylacetic acid
CID 81344572
2-[1-(3,5-dimethylphenyl)-4-methylimidazol-2-yl]sulfanylacetic acid
CID 81337210
2-[1-(3-iodo-4-methylphenyl)-4-methylimidazol-2-yl]sulfanylacetic acid
CID 114257775
2-[1-(4-bromo-3,5-dimethylphenyl)-4-methylimidazol-2-yl]sulfanylacetic acid
CID 107576730
2-[1-(4-ethylphenyl)-4-methylimidazol-2-yl]sulfanylacetic acid
CID 81337042
2-[1-(2,6-dibromo-4-methylphenyl)-4-methylimidazol-2-yl]sulfanylacetic acid
CID 81336771
2-[4-methyl-1-(2,3,4-trifluorophenyl)imidazol-2-yl]sulfanylacetic acid
CID 81337694
2-[1-(2-bromo-4-chlorophenyl)-4-methylimidazol-2-yl]sulfanylacetic acid
CID 81343540

Frequently Asked Questions

What is the IUPAC name of 2-[1-[3-(dimethylamino)phenyl]-4-methylimidazol-2-yl]sulfanylacetic acid?
The IUPAC name of 2-[1-[3-(dimethylamino)phenyl]-4-methylimidazol-2-yl]sulfanylacetic acid (CID 115378964) is 2-[1-[3-(dimethylamino)phenyl]-4-methylimidazol-2-yl]sulfanylacetic acid.
What is the SMILES notation for 2-[1-[3-(dimethylamino)phenyl]-4-methylimidazol-2-yl]sulfanylacetic acid?
The canonical SMILES for 2-[1-[3-(dimethylamino)phenyl]-4-methylimidazol-2-yl]sulfanylacetic acid is Cc1cn(-c2cccc(N(C)C)c2)c(SCC(=O)O)n1.
What is the InChIKey of 2-[1-[3-(dimethylamino)phenyl]-4-methylimidazol-2-yl]sulfanylacetic acid?
The InChIKey is SWIRMTQXXBZEJC-UHFFFAOYSA-N. The full InChI is InChI=1S/C14H17N3O2S/c1-10-8-17(14(15-10)20-9-13(18)19)12-6-4-5-11(7-12)16(2)3/h4-8H,9H2,1-3H3,(H,18,19).
What are the key properties of 2-[1-[3-(dimethylamino)phenyl]-4-methylimidazol-2-yl]sulfanylacetic acid?
2-[1-[3-(dimethylamino)phenyl]-4-methylimidazol-2-yl]sulfanylacetic acid has a molecular weight of 291.38 g/mol, XLogP of 2.42, 5 rotatable bonds, 1 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[1-[3-(dimethylamino)phenyl]-4-methylimidazol-2-yl]sulfanylacetic acid is sourced from PubChem (CID 115378964), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).